Profile data is unavailable for this security.
About the company
Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company principally engaged in the development, manufacture and sale of non-patented pharmaceutical medicines. The products include intermediate pharmaceutical, bulk medicines and finished drugs. The Company operates its business through two segments. The Intermediates and Bulk Medicines segment is engaged in the manufacture and sale of intermediates and bulk medicines. The Finished Drugs segment is engaged in the manufacture and sale of finished drugs, including antibiotics finished drugs and non-antibiotics finished drugs.
- Revenue in HKD (TTM)1.16bn
- Net income in HKD606.95m
- Incorporated2002
- Employees1.18k
- LocationDawnrays Pharmaceutical (Holdings) LtdUnits 3001-02, 30/F, CNT Tower, Wanchai Hong KongHKG
- Phone+852 21119708
- Fax+852 21119870
- Websitehttps://www.dawnrays.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jbm (Healthcare) Ltd | 648.42m | 130.46m | 1.06bn | 279.00 | 8.72 | 1.10 | 5.77 | 1.64 | 0.1479 | 0.1479 | 0.7338 | 1.17 | 0.4645 | 4.25 | 5.98 | 2,324,068.00 | 9.83 | 4.38 | 12.04 | 5.52 | 52.14 | 46.47 | 21.16 | 12.69 | 1.25 | 89.68 | 0.1155 | 32.98 | 24.62 | 16.09 | 128.51 | 19.99 | 2.26 | -- |
| SinoMab Bioscience Ltd | 2.18m | -215.18m | 1.30bn | 214.00 | -- | 4.35 | -- | 594.93 | -0.2066 | -0.2066 | 0.0021 | 0.2734 | 0.0023 | -- | -- | 10,156.98 | -22.83 | -24.62 | -29.11 | -27.72 | 26.80 | -- | -9,853.75 | -4,451.74 | -- | -81.79 | 0.6339 | -- | -- | -- | 14.45 | -- | 106.81 | -- |
| Essex Bio-Technology Ltd | 1.62bn | 262.89m | 1.47bn | 1.46k | 5.76 | 0.7293 | 4.63 | 0.9077 | 0.4499 | 0.4499 | 2.73 | 3.55 | 0.5587 | 2.62 | 2.73 | 1,093,064.00 | 9.07 | 11.20 | 12.10 | 14.73 | 89.78 | 86.01 | 16.24 | 19.77 | 1.61 | -- | 0.1397 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
| Jacobson Pharma Corporation Ltd | 1.47bn | 210.24m | 1.50bn | 1.72k | 6.85 | 0.6261 | 4.26 | 1.02 | 0.1095 | 0.1391 | 0.7644 | 1.20 | 0.3311 | 2.47 | 6.37 | 851,885.10 | 4.74 | 4.30 | 5.76 | 5.57 | 42.27 | 41.25 | 14.32 | 13.73 | 1.73 | 5.33 | 0.2382 | 40.62 | 15.79 | -0.1401 | 1.31 | -3.05 | 24.06 | 4.10 |
| Ascletis Pharma Inc | 10.88m | -278.60m | 1.59bn | 219.00 | -- | 0.6982 | -- | 145.81 | -0.2684 | -0.2684 | 0.0105 | 2.32 | 0.0041 | 1.34 | 3.58 | 49,660.47 | -10.47 | -6.43 | -10.85 | -6.64 | -125.17 | 35.67 | -2,561.69 | -243.38 | 24.31 | -- | 0.004 | -- | 4.63 | -19.39 | 54.04 | -- | -20.44 | -- |
| Cryofocus Medtech Shanghai Co Ltd | 44.74m | -114.53m | 1.65bn | 370.00 | -- | 13.03 | -- | 36.98 | -0.479 | -0.479 | 0.1871 | 0.5311 | 0.1881 | 0.418 | 4,369.58 | 114,140.80 | -51.79 | -- | -66.30 | -- | 76.35 | -- | -275.28 | -- | 2.06 | -80.68 | 0.2303 | -- | 50.83 | -- | 13.13 | -- | -- | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.16bn | 606.95m | 1.86bn | 1.18k | 3.07 | 0.5282 | 2.72 | 1.60 | 0.404 | 0.404 | 0.7741 | 2.35 | 0.2838 | 2.05 | 6.17 | 1,017,201.00 | 14.74 | 9.89 | 17.79 | 12.49 | 56.58 | 56.69 | 51.92 | 27.89 | 3.04 | -- | 0.0544 | 35.33 | -9.90 | 3.94 | -8.95 | 1.41 | 63.92 | 2.00 |
| VIVA Biotech Holdings | 2.15bn | -342.76k | 1.97bn | 2.04k | -- | 0.4825 | 7.85 | 0.9167 | -0.0054 | -0.0054 | 1.05 | 1.91 | 0.2603 | 5.26 | 5.18 | 1,035,423.00 | 0.4017 | -1.39 | 0.5601 | -1.68 | 33.66 | 34.81 | 1.54 | -5.44 | 1.46 | 3.19 | 0.2884 | -- | -9.42 | 59.31 | 78.03 | -- | 31.98 | -- |
| Golden Throat Holdings Group Co Ltd | 1.08bn | 282.63m | 2.31bn | 860.00 | 8.19 | 1.67 | 7.13 | 2.13 | 0.3823 | 0.3823 | 1.47 | 1.87 | 0.4994 | 3.23 | 4.07 | 1,248,098.00 | 13.01 | 11.00 | 19.26 | 15.63 | 72.29 | 72.79 | 26.06 | 24.67 | 1.93 | 37.74 | 0.2814 | 83.15 | -3.09 | 6.73 | -11.04 | 19.61 | -32.13 | 38.94 |
Data as of Nov 13 2024. Currency figures normalised to Dawnrays Pharmaceutical (Holdings) Ltd's reporting currency: Hong Kong Dollar HKD
11.32%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 30 Sep 2024 | 104.84m | 6.99% |
| UBS Asset Management (Hong Kong) Ltd.as of 31 Jul 2024 | 37.04m | 2.47% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 13.43m | 0.90% |
| Fidelity Investments Canada ULCas of 30 Sep 2024 | 7.76m | 0.52% |
| CATAM Asset Management AGas of 31 Mar 2021 | 3.23m | 0.22% |
| Strategic Advisers LLCas of 31 Aug 2024 | 2.38m | 0.16% |
| Dimensional Fund Advisors Ltd.as of 31 Aug 2024 | 713.60k | 0.05% |
| DFA Australia Ltd.as of 30 Sep 2024 | 222.23k | 0.02% |
| Acadian Asset Management LLCas of 30 Sep 2024 | 150.04k | 0.01% |
| FIL Investments Internationalas of 30 Jun 2024 | 76.43k | 0.01% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
